Manipal Hospitals
| India | Turkey | Austria | |
| Stereotaxic radiosurgery | from $5,200 | from $4,500 | from $17,000 |
| Radiation therapy for colorectal cancer | from $3,200 | from $7,000 | from $12,000 |
| Craniotomy | from $5,733 | from $5,650 | from $20,000 |
| Chemotherapy for breast cancer | from $3,500 | from $1,200 | from $15,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Medulloblastoma treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Medulloblastoma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Medulloblastoma treatment journey.
Head and Chief of Neurosurgery at BLK Super Speciality Hospital – specializes in neuro-oncology and minimally invasive techniques.
Dr. Sridhar specializes in radiotherapy for complex brain tumors at HCG Manavata Cancer Centre.
Handled more than 30,000 PET scans and 1,000 thyroid cancer patients – Dr. Borde brings extensive nuclear medicine expertise to medulloblastoma cases.
Medulloblastoma treatment in India follows multi-modal protocols including maximal safe surgical resection, risk-stratified craniospinal irradiation, and systemic chemotherapy. Indian centers utilize advanced Volumetric Modulated Arc Therapy and Proton Beam Therapy. Treatment intensity is adjusted based on age, tumor residual, and molecular subtyping.
Bookimed Expert Insight: Quality of care in India is concentrated in high-volume oncology clusters like Chennai and Gurgaon. Clinics such as Global Hospital Chennai and Fortis Gurgaon utilize linear accelerators with 1 mm accuracy. These facilities serve up to 80,000 patients annually. This high volume ensures surgeons maintain the precision required for complex posterior fossa resections.
Patient Consensus: Patients emphasize the need for large tertiary cancer centers over smaller hospitals for this complex surgery. They note that long-term follow-up must include regular hearing checks and neurodevelopment monitoring.
Indian specialists achieve cure rates of 70% to 85% for standard-risk medulloblastoma in children. Success depends on early diagnosis and complete surgical removal. Major centers in India follow international neuro-oncology protocols. These combine precision neurosurgery, craniospinal radiation, and intensive chemotherapy.
Bookimed Expert Insight: India has become a global hub for neuro-oncology because it offers high-volume clinical expertise at facilities like HCG Manavata Cancer Centre. This clinic has treated over 100,000 patients and maintains a staff of 40+ oncologists. For medulloblastoma, success is linked to the surgeon’s experience. Dr. Raj Nagarkar has performed over 50,000 surgeries, showing the deep technical skill available in Indian specialized centers.
Patient Consensus: Patients emphasize that receiving a second opinion is vital to confirm risk stratification. They often highlight that while treatment is effective, focusing on long-term rehabilitation for side effects like fatigue is necessary.
Medulloblastoma treatment risks include neurological deficits from surgery, hearing loss from chemotherapy, and hormonal imbalances after radiation. Long-term side effects often manifest as cognitive delays, growth deficiencies, and impaired coordination. Specialized Indian centers utilize linear accelerators with 1mm accuracy to minimize damage to healthy brain tissue.
Bookimed Expert Insight: Coordination of care is the most critical factor for long-term outcomes in India. Top-tier facilities like Global Hospital Chennai and HCG Manavata Cancer Centre integrate pediatric oncology with specialized audiology and endocrinology. Choosing a center with these built-in support services ensures early detection of late effects like hearing loss or growth hormone deficiency without needing separate referrals.
Patient Consensus: Patients note it is vital to request baseline hearing tests before starting chemotherapy and to emphasize fertility preservation early. Families frequently highlight that daily stamina and school performance may lag even when follow-up scans show clear results.
Medical centers in Chennai, Gurgaon, Mumbai, and Bengaluru offer high-level expertise for medulloblastoma treatment. These hubs feature specialized pediatric tumor boards and advanced neuro-navigation. Facilities like Apollo Proton Cancer Centre and HCG Cancer Hospital provide precision radiation essential for protecting developing tissues.
Bookimed Expert Insight: Patient volume data often reveals hidden specializations. While many associate Gurgaon with adult transplants, Medanta manages 20,000 patients annually with a heavy focus on complex neuro-oncology imaging. For pediatric cases, choosing a facility like HCG Manavata, which manages 75,000 patients yearly, ensures access to doctors like Dr. Shruti Kate who have specific training from India's apex cancer institutes.
Patient Consensus: Families emphasize finding a hospital that coordinates surgery, radiation, and chemotherapy in one location. Many recommend getting a second pathology opinion from major metro centers to confirm the specific tumor subtype before starting treatment.
International families should plan a stay of 7 to 10 months for complete medulloblastoma treatment in India. This duration covers surgery, craniospinal radiation, and maintenance chemotherapy. Families can reduce this stay to approximately 3 months by completing the final chemotherapy phase in their home country.
Bookimed Expert Insight: Choosing centers with integrated research and high patient volumes, such as HCG Manavata Cancer Centre which serves 75,000 patients annually, ensures access to specialists like Dr. Shruti Kate who have specific pediatric oncology training. High-volume Indian centers often provide more stable scheduling for complex, multi-phase treatments which helps prevent delays in the 7-month timeline.
Patient Consensus: Families emphasize that the stay is a marathon rather than a sprint, often requiring a `just in case` time cushion for neurologic assessments and pathology reviews. Most suggest booking furnished apartments with kitchens because preparing hygienic, home-cooked meals is vital for children during long chemotherapy cycles.
Indian specialists treat medulloblastoma in children under 3 using radiation-sparing protocols. Surgeons perform maximal safe resection to remove the tumour. Intensive chemotherapy then follows to delay or avoid radiation. This protects the developing brain from long-term side effects and neurocognitive impairment.
Bookimed Expert Insight: Indian oncology centres often offer specialised technologies. These include CyberKnife at Fortis Gurgaon or Versa HD at HCG Manavata. These systems provide sub-millimetre precision. Sparing healthy brain tissue is the priority. For this reason, this high accuracy is vital for treating infants. HCG Manavata alone has treated over 100,000 international patients. This shows deep experience in complex paediatric cases.
Patient Consensus: Parents in India highlight that a radiation-sparing approach helps prevent long-term toxicity. They also suggest arranging early rehabilitation. This can help children manage potential side effects like peripheral neuropathy.
Leading Indian centres report 5-year survival rates between 80% and 90% for standard-risk medulloblastoma. For high-risk cases, survival typically ranges from 62% to 76.9%. These outcomes align with Western standards. This is achieved when using intensive protocols involving surgery, craniospinal irradiation, and chemotherapy.
Bookimed Expert Insight: Indian clinics such as HCG Manavata Cancer Centre treat over 75,000 patients annually. This massive case volume allows specialists to refine protocols for rare paediatric cancers. Standard radiation is common. Even so, patients should prioritise centres offering Versa HD or Proton Beam therapy. This helps better protect developing brain tissue.
Patient Consensus: Accuracy in molecular subgrouping is essential for a reliable prognosis in India. Proton Beam therapy offers better long-term cognitive outcomes for children. Families note this improvement over standard irradiation. Patients emphasise confirming the full triad of surgery, radiation, and chemotherapy. This should be included in the plan.
For toddlers in India, medulloblastoma treatment focuses on maximal safe surgery. This is followed by intensive chemotherapy. This approach delays or avoids craniospinal radiation to protect developing brains. Major Indian cancer centres use molecular subgrouping, such as WNT and SHH. This helps tailor therapy and improve survival outcomes.
Bookimed Expert Insight: Indian centres like Fortis Gurgaon and HCG Manavata offer high-density radiotherapy equipment. This includes TrueBeam STx and TomoTherapy-H. These systems specifically help toddlers because they track tumour movement in real-time. This precision means radiation spares healthy tissue. This is vital for children under 3 needing focal treatment.
Patient Consensus: Parents in India emphasise that early molecular testing is vital for avoiding unnecessary radiation. Many note that specialised paediatric oncology teams provide essential support. They help with long-term recovery and cognitive development.
Key staging for medulloblastoma in India involves contrast-enhanced MRI of the brain and spine. This detects central nervous system spread. At JCI-accredited facilities, specialists perform lumbar punctures for cerebrospinal fluid (CSF) cytology within 72 hours of surgery. They also perform molecular subgrouping (WNT, SHH, Group 3, Group 4) within the same timeframe.
Bookimed Expert Insight: Leading Indian cancer centres like HCG Manavata Cancer Centre integrate nuclear medicine. They have handled 30,000+ PET scans. While basic centres focus solely on spinal spread, high-volume units use PET-CT and Gamma Cameras. These confirm no systemic extension before starting intensive paediatric radiotherapy.
Patient Consensus: Patients highlight that having digital MRI copies from Australia reduces waiting times in India. Families also note that molecular testing is essential for choosing targeted therapies. This is especially true for high-risk paediatric cases.
Indian oncology centres manage medulloblastoma side effects using radiation techniques and multidisciplinary rehabilitation. Specialists address acute issues like posterior fossa syndrome through speech therapy. They also monitor long-term endocrine and cognitive health. Facilities in Gurgaon and Chennai provide targeted care to reduce treatment toxicity.
Bookimed Expert Insight: India houses some of the world's most technically sophisticated oncology units. Fortis Gurgaon is ranked second globally for its medical technology. It uses intraoperative neuromonitoring and neuronavigation during medulloblastoma surgery. These tools help surgeons remove tumours while protecting motor and speech functions. This lowers the risk of permanent deficits.
Patient Consensus: Patients in India find that daily naps are essential for managing severe radiation-induced fatigue. They also note that posterior fossa syndrome is common but temporary. It typically requires two months for speech and eye movement to recover.
Indian oncology centres offer medulloblastoma radiation including proton therapy, CyberKnife, and TomoTherapy-H. These technologies target tumours while sparing healthy brain tissue. Specialists use craniospinal irradiation to treat the entire nervous system. Facilities like Fortis Gurgaon and HCG Manavata provide these high-precision treatments.
Bookimed Expert Insight: Radiation infrastructure in India is concentrated in specialised hubs. HCG Manavata Cancer Centre has treated over 25,000 radiotherapy patients. It was the first to introduce TomoTherapy-H in its region. Choosing a high-volume centre is vital for medulloblastoma. These facilities often combine 4D radiotherapy with intraoperative neuromonitoring. This helps neurological functions stay intact during and after intensive treatment protocols.
Patient Consensus: Patients note India provides technology like MR-LINAC at lower costs than Australia. They emphasise verifying if a clinic can handle the full craniospinal irradiation required.
Specialists in India determine medulloblastoma risk using clinical, radiological, and molecular analysis following Indian Society of Neuro-Oncology guidelines. Diagnosis involves MRI staging and molecular subgrouping (WNT, SHH, Group 3, or Group 4). These factors dictate whether treatment requires surgery, craniospinal irradiation, or intensive chemotherapy.
Bookimed Expert Insight: Indian neuro-oncology centres have extensive experience with complex paediatric cases. HCG Manavata Cancer Centre has performed 65,000+ cancer surgeries. Specialists like Dr Vikas Gupta at BLK Super Speciality Hospital lead dedicated programs for medulloblastoma. This high volume allows these teams to refine surgical techniques. These often result in better functional recovery for young patients.
Patient Consensus: Patients advise that their pathology report includes molecular subgrouping to confirm if radiation can be avoided. Many note that Indian hospitals offer excellent neuro-oncology expertise and access to standard protocols.
India provides medulloblastoma treatment at JCI and NABH-accredited facilities like Medanta and Fortis. These centres specialise in complex neuro-oncology. Surgeons use techniques like craniotomy and resection. Integrated care often includes radiation and chemotherapy protocols to treat paediatric brain tumours effectively.
Bookimed Expert Insight: Patients often find that choosing clinics in Nashik or Gurgaon provides better value. Records show HCG Manavata operates with US-FDA audited research standards. Fortis Gurgaon is ranked among the world's most technically advanced hospitals. Both provide access to high-end radiation like TomoTherapy-H or CyberKnife. This is vital for preserving healthy brain tissue.
Patient Consensus: Patients value the dedicated international departments in Mumbai and Gurgaon that streamline visas. Many highlight the cost-effectiveness of private Indian institutions compared to Western options. Experience shows that seeking a second opinion from Mumbai-based specialists is helpful for complex paediatric cases.
Surgery for deep medulloblastoma focuses on maximum safe resection. This means removing as much tissue as possible without damaging vital structures. Indian neurosurgeons use techniques like intraoperative neuromonitoring to protect brain function. This procedure is critical for accurate diagnosis and relieving pressure.
Bookimed Expert Insight: Indian centres like HCG Manavata have performed over 65,000 cancer surgeries. Their specialists often combine surgical debulking with radiotherapy like TomoTherapy-H. This integrated approach is vital for deep tumours. In such cases, total removal carries high neurological risks.
Patient Consensus: Patients in India highlight that surgery is a mandatory first step. This step prevents permanent dysfunction. They often experience temporary speech changes during recovery. However, they note that high-volume centres provide better long-term survival.